Verve Therapeutics Statistics
Total Valuation
VERV has a market cap or net worth of $485.97 million. The enterprise value is $17.31 million.
Important Dates
The last earnings date was Tuesday, November 5, 2024, before market open.
| Earnings Date | Nov 5, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
VERV has 84.66 million shares outstanding. The number of shares has increased by 29.46% in one year.
| Current Share Class | 84.66M |
| Shares Outstanding | 84.66M |
| Shares Change (YoY) | +29.46% |
| Shares Change (QoQ) | +0.48% |
| Owned by Insiders (%) | 5.33% |
| Owned by Institutions (%) | 68.80% |
| Float | 55.94M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 18.92 |
| Forward PS | 36.41 |
| PB Ratio | 0.96 |
| P/TBV Ratio | 0.96 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.71 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 13.05, with a Debt / Equity ratio of 0.14.
| Current Ratio | 13.05 |
| Quick Ratio | 12.72 |
| Debt / Equity | 0.14 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -40.67% and return on invested capital (ROIC) is -25.35%.
| Return on Equity (ROE) | -40.67% |
| Return on Assets (ROA) | -22.19% |
| Return on Capital (ROIC) | -25.35% |
| Revenue Per Employee | $95,671 |
| Profits Per Employee | -$772,651 |
| Employee Count | 255 |
| Asset Turnover | 0.04 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, VERV has paid $308,000 in taxes.
| Income Tax | 308,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -59.86% in the last 52 weeks. The beta is 1.72, so VERV's price volatility has been higher than the market average.
| Beta (5Y) | 1.72 |
| 52-Week Price Change | -59.86% |
| 50-Day Moving Average | 5.76 |
| 200-Day Moving Average | 6.48 |
| Relative Strength Index (RSI) | 49.30 |
| Average Volume (20 Days) | 1,760,471 |
Short Selling Information
The latest short interest is 17.87 million, so 21.11% of the outstanding shares have been sold short.
| Short Interest | 17.87M |
| Short Previous Month | 17.08M |
| Short % of Shares Out | 21.11% |
| Short % of Float | 31.95% |
| Short Ratio (days to cover) | 11.25 |
Income Statement
In the last 12 months, VERV had revenue of $24.40 million and -$197.03 million in losses. Loss per share was -$2.45.
| Revenue | 24.40M |
| Gross Profit | -171.71M |
| Operating Income | -226.54M |
| Pretax Income | -192.38M |
| Net Income | -197.03M |
| EBITDA | -219.97M |
| EBIT | -226.54M |
| Loss Per Share | -$2.45 |
Full Income StatementBalance Sheet
The company has $539.92 million in cash and $71.26 million in debt, giving a net cash position of $468.67 million or $5.54 per share.
| Cash & Cash Equivalents | 539.92M |
| Total Debt | 71.26M |
| Net Cash | 468.67M |
| Net Cash Per Share | $5.54 |
| Equity (Book Value) | 508.55M |
| Book Value Per Share | 6.01 |
| Working Capital | 513.82M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$157.53 million and capital expenditures -$4.53 million, giving a free cash flow of -$162.06 million.
| Operating Cash Flow | -157.53M |
| Capital Expenditures | -4.53M |
| Free Cash Flow | -162.06M |
| FCF Per Share | -$1.91 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | -928.60% |
| Pretax Margin | -806.35% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
VERV does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -29.46% |
| Shareholder Yield | -29.46% |
| Earnings Yield | -40.54% |
| FCF Yield | -33.35% |
Analyst Forecast
The average price target for VERV is $25.75, which is 348.61% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $25.75 |
| Price Target Difference | 348.61% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (5Y) | 17.52% |
| EPS Growth Forecast (5Y) | 2.61% |
Stock ForecastsStock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
VERV has an Altman Z-Score of 1.23 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.23 |
| Piotroski F-Score | 3 |